The AHA Guidelines and Scientific Statements Handbook

(vip2019) #1

Index


Diltiazem 17, 33, 64–5, 75, 204, 208–10, 245, 251, 258,
260–2, 264–5, 267, 276, 291
Dinitrate, isosorbide 232, 235
Diphtheria 241
Disability 214–5, 221–2
Disopyramide 246, 250–1, 265, 268, 290
Dissection 345
aortic 53–4, 339, 344–5
fl ow-limiting 179
iatrogenic 344
Diuretics 204, 209–11, 229, 231, 233–4, 288
loop 228
potassium-sparing 228
thiazide 204, 206–13, 228
DM 17, 25, 39–45, 48, 53, 83, 106, 122, 142–3, 154, 156,
158, 162–3, 166–7, 169–71, 173–6, 182, 189–90,
192–3, 195, 196, 200–2, 204–5, 207–10, 212–3, 214,
217, 219–21, 224, 226–7, 232, 234, 241, 247, 282,
283, 291
Dobutamine 81, 83
Docosahexaenoic acid 218
Dofetilide 249–51, 268, 290
Domperidone 290
Door-to-balloon 58, 124
Door-to-Balloon: An Alliance for Quality 90
Door-to-departure 52
Door-to-needle 50, 58
Doppler, audible venous 184
Doxazosin 210
Doxorubicin 240–1, 291
Doxycycline 328
Dronedarone 266, 269
Droperidol 290
Drug eluting stent. See DES
Drugs
antiarrhythmic 229, 232, 276–7, 281, 283, 289
anticoagulant 208–9
antihypertensive 173, 204, 213
antiplatelet 209
antithrombotic 175
beta blocker 289
blocking 229–30
chemotherapy 225–6
cholesterol-lowering 194
classes 208, 210
illicit 225–6
inotropic 230
nephrotoxic 317
nonsteroidal anti-infl ammatory 229, 317
QT-prolonging 290
triglyceride-lowering 192
Duchenne–Becker disease 241
Duke criteria 155, 312–4


Dysbetalipoproteinemia 192
Dysfunction
left ventricular 227, 234, 270, 278
myocardial 129, 276
pulmonary 143
Dyslipidemia 166, 171, 173, 202, 210, 215
atherogenic 193
secondary 189
Dysplasia 238
Dyspnea 157, 255, 272
Dysrhythmia 66, 178
Dystrophin 241

EBCT 336–7, 340–2
ECG 5–10, 12, 23–5, 31–3, 39, 51–4, 56, 59, 62, 66, 68–71,
81–3, 120, 154, 158, 163, 239–40, 256–9, 262, 265,
273–4, 289, 294, 336
Echocardiography 3, 6–14, 23–4, 39, 53–4, 69–71, 80–3,
137, 139, 144, 160, 162, 225, 238, 240, 252, 274,
289, 291, 294–311, 313–6, 323, 325, 340
ECMA trial 281
Edema 58, 60, 69, 70, 72–3, 202, 231
pulmonary 160
EF 61, 73–4, 81, 87, 127, 226–7, 233–4, 271–3, 281, 297,
300–1, 305–8
Eicosapentaenoic acid 218
Ejection fraction. See EF
Electrical storm 287
Electrophysiological testing 275, 291
Electron beam computed tomography. See EBCT
Embolectomy 186
Embolism 68, 80, 83, 246, 248–9, 326, 328, 330,
344–5
arterial 314
pulmonary 80, 345
recurrent 310
Embolization 302, 316, 326
Embryogenesis, normal 239
Emergency medical services systems. See EMS
Emerin 241
Emery Dreifuss muscular dystrophy 241
EMS 48, 50–2, 88
Enalapril 227
Encode 239–40
End-of-life 231, 233–4, 236
End-stage renal disease. See ESRD
End-systolic dimension. See SD
Endarterectomy
carotid 138
iliac 179–80, 183
Endocarditis 294, 308–10, 312–35
acquisition 334
active 314
Free download pdf